financetom
Business
financetom
/
Business
/
SM Energy Q3 profit beats estimates, production up 26%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SM Energy Q3 profit beats estimates, production up 26%
Nov 3, 2025 3:49 AM

Overview

* SM Energy ( SM ) Q3 adjusted EPS beats analyst expectations, reflecting strong operational performance

* Company Q3 net income at $155.1 mln, despite lower realized prices

* SM Energy ( SM ) returned $35.1 mln to shareholders via dividends and share repurchases

Outlook

* SM Energy ( SM ) sees full-year production at 207-208 MBoe/d with 53-54% oil

* Company expects Q4 production of 206-212 Mboe/d with 52-53% oil

* SM Energy ( SM ) raises full-year capex to $1.375-$1.395 bln due to well acquisitions

Result Drivers

* STRONG PRODUCTION - SM Energy's Q3 production totaled 19.7 MMBoe, with a 26% increase in net daily production and a 47% rise in net daily oil production compared to Q3 2024

* RESILIENT MARGINS - Despite a $10/Bbl drop in oil prices, SM Energy ( SM ) maintained nearly flat cash production margins due to increased oil-weighted production from Uinta Basin

* INCREASED RETURNS - SM Energy ( SM ) returned $35.1 mln to shareholders through dividends and share repurchases, reflecting improved leverage and financial strategy

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $1.33 $1.28

Adjusted (14

EPS Analysts

)

Q3 EPS $1.35

Q3 Net $155.08

Income mln

Q3 Basic $1.35

EPS

Q3 $246.48

Income mln

From

Operatio

ns

Q3 $204.29

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the oil & gas exploration and production peer group is "buy"

* Wall Street's median 12-month price target for SM Energy Co ( SM ) is $37.00, about 43.5% above its October 31 closing price of $20.89

* The stock recently traded at 4 times the next 12-month earnings vs. a P/E of 5 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kits Eyecare Says Acquiring Over $1 Million In Organic, Recurring Business Per Week
Kits Eyecare Says Acquiring Over $1 Million In Organic, Recurring Business Per Week
Jul 11, 2024
10:00 AM EDT, 07/11/2024 (MT Newswires) -- Kits Eyecare ( KTYCF ) announced Thursday a weekly record for new customer acquisition of $1.2 million, the second weekly record in as many weeks. The company says it is acquiring more than $1 million of organic, recurring business per week. An expansion of its branded contact lenses and direct billing partnerships with...
Anika Therapeutics Extends Availability of Integrity Implant  System
Anika Therapeutics Extends Availability of Integrity Implant System
Jul 11, 2024
10:04 AM EDT, 07/11/2024 (MT Newswires) -- Anika Therapeutics ( ANIK ) said Thursday its Integrity Implant System is now broadly available throughout the US after being in limited release since last November. The system is designed to protect injured tendons and promote healing following rotator cuff and other tendon repair procedures. According to the company, the hyaluronic acid-based Integrity...
Argan Insider Sold Shares Worth $1,176,910, According to a Recent SEC Filing
Argan Insider Sold Shares Worth $1,176,910, According to a Recent SEC Filing
Jul 11, 2024
10:01 AM EDT, 07/11/2024 (MT Newswires) -- Rainer H Bosselmann, Director, on July 10, 2024, sold 17,000 shares in Argan (AGX) for $1,176,910. Following the Form 4 filing with the SEC, Bosselmann has control over a total of 247,719 shares of the company, with 247,719 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/100591/000141588924019478/xslF345X03/form4-07112024_010704.xml Price: 69.78, Change: +0.02, Percent Change: +0.03 ...
What's Going On With Cara Therapeutics Stock?
What's Going On With Cara Therapeutics Stock?
Jul 11, 2024
Cara Therapeutics Inc ( CARA ) shares are trading higher by 11.5% to 32 cents during Thursday’s session. The company earlier announced it engaged Piper Sandler & Co. as a financial advisor to explore strategic alternatives to enhance shareholder value. CEO Christopher Posner stated that the company aims to evaluate various options while implementing a cost-containment and cash conservation plan....
Copyright 2023-2026 - www.financetom.com All Rights Reserved